Literature DB >> 19493644

Prosthetic joint infection risk after total hip arthroplasty in the Medicare population.

Kevin L Ong1, Steven M Kurtz, Edmund Lau, Kevin J Bozic, Daniel J Berry, Javad Parvizi.   

Abstract

Periprosthetic joint infection is one of the most challenging complications of total joint arthroplasty. We evaluated the incidence of early-onset (less than 2 years) and late-onset (greater than 2 years) periprosthetic joint infection after primary total hip arthroplasty (THA). The Medicare 5% national sample data set (1997-2006) was used to longitudinally follow primary THA patients. Deep infections were identified with the International Classification of Diseases, Ninth Revision, Clinical Modification code 996.66. Kaplan-Meier survivorship curves were compiled with infection as the end point. Cox regression was used to evaluate patient and hospital characteristics. Eight hundred eighty-seven THA infections were identified from 39,929 THA patients. The incidence of infection was 1.63% within 2 years and 0.59% between 2 and 10 years. Comorbidities, sex, procedure duration, and socioeconomic status were found to be significant risk factors. This is the first study to establish the incidence and risk factors associated with early onset and delayed periprosthetic joint infection in the Medicare patient population.

Entities:  

Mesh:

Year:  2009        PMID: 19493644     DOI: 10.1016/j.arth.2009.04.027

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  128 in total

1.  Operating room traffic is a major concern during total joint arthroplasty.

Authors:  Pedram Panahi; Mitchell Stroh; David S Casper; Javad Parvizi; Matthew S Austin
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

Review 2.  [Septic endoprosthesis exchange : Preoperative diagnosis and reimplantation].

Authors:  H M L Mühlhofer; J Schauwecker; I J Banke; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2015-12       Impact factor: 1.087

3.  Is two-stage reimplantation effective for virulent pathogenic infection in a periprosthetic hip? A retrospective analysis.

Authors:  Yong-Cheol Yoon; Devendra Lakhotia; Jong-Keon Oh; Jun Gyu Moon; Kumar Prashant; Won Yong Shon
Journal:  World J Orthop       Date:  2015-10-18

4.  High Risk of Readmission in Octogenarians Undergoing Primary Hip Arthroplasty.

Authors:  Arthur L Malkani; Brian Dilworth; Kevin Ong; Doruk Baykal; Edmund Lau; Theresa N Mackin; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2017-12       Impact factor: 4.176

5.  [Indications for joint replacement : Total hip arthroplasty].

Authors:  S Rahm; P O Zingg
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

6.  Molecular characterization of an early invasive Staphylococcus epidermidis prosthetic joint infection.

Authors:  Marnie E Rosenthal; Lisa L Dever; Calin S Moucha; Kalyan D Chavda; Michael Otto; Barry N Kreiswirth
Journal:  Microb Drug Resist       Date:  2011-04-21       Impact factor: 3.431

7.  Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years.

Authors:  Richard Blomfeldt; Piotr Kasina; Carin Ottosson; Anders Enocson; Lasse J Lapidus
Journal:  Int Orthop       Date:  2015-09-18       Impact factor: 3.075

8.  Diagnosis of periprosthetic joint infection in Medicare patients: multicriteria decision analysis.

Authors:  Claudio Diaz-Ledezma; Paul M Lichstein; James G Dolan; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176

9.  Do claims-based comorbidities adequately capture case mix for surgical site infections?

Authors:  Hilal Maradit Kremers; Laura W Lewallen; Brian D Lahr; Tad M Mabry; James M Steckelberg; Daniel J Berry; Arlen D Hanssen; Elie F Berbari; Douglas R Osmon
Journal:  Clin Orthop Relat Res       Date:  2014-12-06       Impact factor: 4.176

10.  Prosthetic joint infections.

Authors:  Saima Aslam; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.